Avid Bioservices Inc (CDMO)

[BKT]

My take:

1) No doubt that new Avid facility is a huge add for bottom line, I think anyone investing in this company has to incorporate the value of AVID alone. I mean at 50 million a year and a 51% GP, that value has to be pretty good ( maybe even now somewhere between .50 and up.

2) They are very confident of the Sunrise approval ( which also relates to expansion of AVID above), double hit there and are also wanting to rapidly initiate other trials to add on to the data to expedite the approval process once the Sunrise trial is complete.

3) Treatment landscape will continue to provide areas for the use of Bavi to show how it can enhance other drugs.

Very impressed with the call, I believe we are on the way, but very disappointed that nothing was brought up about the 175 million. For me another finger up at shareholders.